Is There a Role for Pharmacokinetic/Pharmacodynamics Guided Dosing for Novel Anticoagulants?

Read the paper here: Is There A Role For Pharmacokinetic/Pharmacodynamic Guided Dosing For Novel Oral Anticoagulants?

Chan Noel, Sager Philip T., Lawrence Jack, Ortel Thomas’s, Reilly Paul, Berkowitz Scott, Kubitza Dagmar, Eikelboom John, Florian Jeffry, Stockbridge Norman, Rose Martin, Temple Robert, Seltzer Jonathan H., Is There A Role For Pharmacokinetic/Pharmacodynamic Guided Dosing For Novel Oral Anticoagulants?, American Heart Journal (2017)

NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A Cardiac Safety Research Consortium think tank

Read the paper here: NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A Cardiac Safety Research Consortium think tank

Reiffel JA, et al. NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank. Am Heart J. 2016; 177: 74-86